Delivery Order SPE2DR25D2007-SPE2DR26FM20A
Award Date 12/1/25
Potential Completion Date 12/2/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement medication, with a ceiling value of $2,979.09. This is a firm fixed price delivery order with an ultimate completion date of December 3, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement medication. This firm fixed-price delivery order, valued at $11,775.31, represents a competitively awarded contract with an ultimate completion date of August 29, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with no set-aside designation applied to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for 36,000 units of Creon DR 100s capsules, valued at $2,704.53. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of December 12, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement therapy medication. This firm fixed-price delivery order, valued at $1,856.40, was issued without a set-aside designation and is scheduled for completion by June 26, 2025. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for 24,000 units of Creon DR 100s capsules, a pancreatic enzyme supplement medication. This competitively awarded, non-set-aside contract carries a ceiling value of $3,042.77 and is classified as a firm fixed price delivery order with an ultimate completion date of August 27, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement medication. This competitively awarded, non-set-aside order carries a firm fixed price of $13,340.29 and is scheduled for completion by June 17, 2025. The products will be delivered to the company's headquarters in Conshohocken, Pennsylvania, and serve federal medical procurement needs, particularly for...
- The Defense Logistics Agency awarded a delivery order valued at $14,157.97 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s, a pancreatic enzyme replacement medication. The award was issued on December 3, 2025, with an ultimate completion date of December 4, 2025, and utilized firm fixed price pricing with no set-aside designation. Performance of this delivery order will take place at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement therapy, with a contract ceiling value of $14,334.96. This competitive, non-set-aside delivery order is firm fixed price with an ultimate completion date of November 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR (pancreatic enzyme replacement therapy) in 100-count capsule bottles, with a contract value of $2,449.64 and a completion date of November 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on November 26, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $10,494.25 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s on November 17, 2025, with completion expected by November 18, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of the vendor's pharmaceutical supply support to federal military and healthcare systems. The contract was executed under a non-set-aside procurement process, underscoring AmerisourceBergen's...